Responsibilities:• Lead scientific, clinical, and business development teams• Serve as key member of executive team during periods of downsizing and subsequent growth• Guide new and existing product roadmaps • Provide P&L leadership of Clinical Services businessAccomplishments: • Demonstrated POC & launched a novel oncology product• Tripled YOY revenue while increasing margin of genetics diagnostics business• Reorganized and right-sized the organization to meet business needs• Designed and implemented plans for the next wave of new products & services• Revised and demonstrated successful POC of GTM strategy• Mentored and professionally developed team of scientists and business developers

Responsibilities:• Contribute to the initial and ongoing corporate strategy and business plan• Build and lead scientific & medical team including physicians, scientists, and laboratory personnel• Design and implement the scientific functionality of cloud platform and mobile applications. • Build NGS clinical laboratory for human whole genome sequencing• Establish NGS analytics for company, including clinical variant interpretation and reporting • Engage external community, partners, KOLs, and customers to grow the business• Business Development & Sales while wearing CSO hat• Create B2B relationships and build team of external academic and medical advisors• Legal and corporate governance/policy design and implementation• Scientific and medical content to broadly support products• Investor relationships and media interviews• Site-leader for Indianapolis based employees (corporate headquarters)Accomplishments: • Partnered with founders to design and implement the corporate strategy (1st-wave employee)• Hired scientific staff and led them from concept through product and service delivery• Guided software architects to create critical functionality of our cloud platform and other products • Created an end-to-end clinical WGS laboratory using the latest automation and technologies • Oversaw budget, personnel, external relationships and other critical business functions of the science and medical organization• Established relationships with KOLs and business partners to grow the business• Partnered with legal and others to create numerous corporate policies, practices, and procedures• Led team to create scientific and medical content in our products• Recruited large team of external advisors to help guide content and grow business• Created and managed large commercial accounts

➢ Strategic development and leadership of Genomics R&D through:• Plan, direct and coordinate the efforts of research and development scientists to identify new product opportunities and to design, develop, and transfer to manufacturing NGS and other genetic sample preparation and automation applications• Define and translate product requirements into product designs and test performance specifications, develop technical solutions to product design and performance issues, and work with other departments within the organization to achieve project objectives and time schedules• Initiate and manage domestic and international collaborations and partnerships with OEMs, industry, and academia• Create and implement innovative solutions to provide competitive advantage• Manage scientific and technical staff; participate in multifunctional project teams; develop and maintain strong collaborative development partnerships with opinion leaders; and ensure all FDA and related regulatory requirements are consistently met• Direct supervision of cross-functional BS/MS/PhD scientists including oversight and supervision of laboratory activities, guidance with professional development, goal and milestone setting, performance management and reviews, and recruiting and retaining top talent.• Contribute to the Development leadership team by providing guidance on project prioritization, resource management, process improvements, and scientific and strategic direction of the Beckman Life Science organization

* Group leader/manager of a team of cancer geneticists and pharmacogenomics scientists using genetics to define patient tailoring strategies for preclinical targets and clinical assets in oncology. Projects include application of Next Generation Sequencing (NGS) to understand disease biology, new target identification/validation, preclinical and clinical patient tailoring hypothesis generation, and clinical biomarker development based on genetic determinants of efficacy and safety. * Responsible for the development and implementation of the NGS strategy at Lilly Research Laboratories. Chair of the internal NGS Core Team that sets corporate strategy and Working Group that enables the successful execution of projects. Established and led multiple NGS (WES/WGS) collaborations with pharma, biotech, and academic scientists in Asia and the United States.* Designed and implemented biomarker and patient stratification projects in support of oncology drug discovery and clinical development programs.* Member of the Tailoring Genetics Management Team to determine project prioritization, cross TA resource management and process improvements.* Lead biologist and project leader of 3 oncology drug discovery efforts. Responsibilities included target identification and validation, setting project goals and strategy, and overall responsibility for project deliverables and accountability. Direction, leadership, and support provided to team members across multiple functional areas including chemistry, ADME, toxicology, medical, legal, informatics, statistics, and in vivo pharmacology.* Current management and supervisory responsibilities of 10-12 direct reports, including 6-7 PhD/MD level scientists. Dotted-line supervision of additional scientists supporting NGS projects. Responsibilities include oversight and supervision of laboratory, clinical trial and bioinformatics activities, goal and milestone setting, mentoring and coaching, and performance management.

* Designed and implemented automated genome-scale cancer target discovery strategies* Conducted several high-throughput cancer gene sequencing projects* Identified and validated multiple oncogenic targets of therapeutic and diagnostic value* Developed an in vivo model of tumor angiogenesis* Designed, expressed, purified, and evaluated anti-angiogenic synthetic toxins